BEHAVE: Benralizumab clinical efficacy, tolerability, and safety in real-world experience with home-based spirometry - Vienna 2024

Taking control: advances in the management of asthma and allergic airways disease

Chair(s): Christian Taube, Francesco Ardesi

Session type: Poster session

BEHAVE: Benralizumab clinical efficacy, tolerability, and safety in real-world experience with home-based spirometry

Slagjana Stoshikj

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Personalized medicine for severe asthma: Machine learning guides biologic treatment choices.

Laila Salameh

Poster

Abstract

Initiation of dupilumab led to reduced use of oral corticosteroids (OCS) and other medications over 12 months in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): A US real-world practice study

Juby Anne Jacob-nara

Poster

Abstract

Efficacy and Safety Analysis of Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis

Changixng Ou

Poster

Abstract

The effects of Benralizumab on blood basophils in severe asthmatic patients: preliminary results

Cecilia Calabrese

Poster

Abstract

BEHAVE: Benralizumab clinical efficacy, tolerability, and safety in real-world experience with home-based spirometry

Slagjana Stoshikj

Poster

Abstract

Real life effectiveness of Mepolizumab in a cohort of patiens with severe eosinophilic asthma and nasal polyposis after 6 years of treatment: a single centre study

Antonio Caso

Poster

Abstract

Real-life Adherence and Evidence of Sublingual Immunotherapy in Allergic Rhinitis and Asthma Among Tunisian Active-Duty Service Members

Yossr Aloulou

Poster

Abstract

Tezepelumab in Real life setting: elucidating the clinical effectiveness, tolerability, and safety in severe asthma patients

Slagjana Stoshikj

Poster

Abstract

Role of Allergen Immunotherapy and Omalizumab as an adjuvant in Asthma remission

Venkatesh Bhat

Abstract

New onset EGPA in patients on biologics for severe asthma (SA)- a multi-centre case series

Hitasha Rupani

Poster

Abstract

Impact of biologic initiation on oral corticosteroids in the International Severe Asthma Registry and the Optimum Patient Care Research Database: a pooled analysis

Wenjia Chen

Poster

Abstract

Oral corticosteroids and biologics use in the Greek Severe Asthma Registry (GSAR)

Evangelia Fouka

Poster

Abstract

Increased inhibitory surface marker PD-1 expression in Th2+T cells in allergen-specific immunotherapy

Yun Liu

Poster

Abstract

Real-world assessment of clinical remission in asthma with biologics

Peter Howarth

Poster

Abstract

Achievement of clinical remission in asthma subgroups based on the combination of FeNO and blood eosinophil counts

Reina Ishii

Poster

Abstract

How, when and why AIT is prescribed in Italy: a real-life study conducted through a patient association

Emanuele Nappi

Abstract

The impact of mepolizumab therapy on Treg proliferation and exhaustion state

Tommaso Pianigiani

Poster

Abstract

Real-world effectiveness of dupilumab vs benralizumab and vs mepolizumab in severe asthma: The EU-ADVANTAGE study

Johann Christian Virchow

Poster

Abstract

Effectiveness of dupilumab vs omalizumab in patients with severe asthma The EU-ADVANTAGE study

Giorgio Walter Canonica

Poster

Abstract

Late Breaking Abstract - IL-33 enhances contractions and mast cell mediator release in isolated human bronchi

Maria Belikova

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}